Akdeniz University Tip Fakultesi Hastanesi
Antalya 07058
0 studies enrolling now · 3 studies all time
What they study most
Obesity, Overweight, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) — Completed
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed